We noted a paucity of HLA class I expression on the cancer cell line (Figure 4B) and identified a single-nucleotide variant resulting in a missense mutation in the B2M gene (c.92C>G) (21) on whole-exome sequencing analysis. Here, B2M is linked to cancer.